Copyright
©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Feb 28, 2013; 19(8): 1173-1181
Published online Feb 28, 2013. doi: 10.3748/wjg.v19.i8.1173
Published online Feb 28, 2013. doi: 10.3748/wjg.v19.i8.1173
Histone deacetylase inhibitors and pancreatic cancer: Are there any promising clinical trials?
Ioannis Koutsounas, Constantinos Giaginis, Stamatios Theocharis, Department of Forensic Medicine and Toxicology, Medical School, University of Athens, GR-11527 Athens, Greece
Constantinos Giaginis, Department of Food Science and Nutrition, University of the Aegean, GR-81400 Lemnos, Greece
Author contributions: Koutsounas I, Giaginis C and Theocharis S contributed to this paper equally.
Correspondence to: Stamatios Theocharis, MD, PhD, Pathologist, Associate Professor of the Department of Forensic Medicine and Toxicology, Medical School, University of Athens, 75, Mikras Asias Street, Goudi, GR11527 Athens, Greece. theocharis@ath.forthnet.gr
Telephone: +30-21-7462413 Fax: +30-21-7716098
Received: June 9, 2011
Revised: October 18, 2011
Accepted: August 15, 2012
Published online: February 28, 2013
Revised: October 18, 2011
Accepted: August 15, 2012
Published online: February 28, 2013
Core Tip